Sort by
Refine Your Search
-
Listed
-
Category
-
Program
-
Field
-
Deadline 25 Aug 2026 - 23:59 (Europe/Brussels) Country Belgium Type of Contract Temporary Job Status Full-time Is the job funded through the EU Research Framework Programme? Not funded by a EU programme Is
-
Deadline 24 Aug 2026 - 23:59 (Europe/Brussels) Country Belgium Type of Contract Temporary Job Status Full-time Is the job funded through the EU Research Framework Programme? Not funded by a EU programme Is
-
Application Deadline 12 May 2026 - 23:59 (Europe/Brussels) Country Belgium Type of Contract Permanent Job Status Full-time Is the job funded through the EU Research Framework Programme? Not funded by a EU
-
Description We are seeking a motivated new PhD candidate who wants to join an exciting collaborative research program within the VIB-Center for Inflammation Research between the Guilliams, Saelens
-
14 May 2026 - 23:59 (Europe/Brussels) Country Belgium Type of Contract Temporary Job Status Full-time Is the job funded through the EU Research Framework Programme? Not funded by a EU programme Is the
-
May 2026 - 23:59 (Europe/Brussels) Country Belgium Type of Contract Permanent Job Status Full-time Is the job funded through the EU Research Framework Programme? Not funded by a EU programme Is the Job
-
) and ATTR (transthyretin) amyloidosis are the most common systemic forms, with distinct molecular origins but shared mechanisms of extracellular amyloid deposition and tissue damage. Our research program
-
Leuven, one of Europe’s leading research universities State of the art research facilities. A dedicated training program to broaden your expertise and enhance your skillset. A competitive compensation
-
(Europe/Brussels) Country Belgium Type of Contract Temporary Job Status Full-time Is the job funded through the EU Research Framework Programme? Not funded by a EU programme Is the Job related to staff
-
Description We are seeking a motivated new PhD candidate who wants to join an exciting collaborative research program within the VIB-Center for Inflammation Research between the Guilliams and